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Objectives: To estimate the heritabilities of maximally attained lung function in young adult
twins, and to examine whether circulating leptin, leptin (LEP) and leptin receptor (LEPR) gene
polymorphisms are associated with maximally attained lung function.
Methods: Measures on forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC)
were available of 578 twins recruited from the East Flanders Prospective Twin Survey (165
monozygotic (MZ) and 73 dizygotic (DZ) complete pairs and 102 single twins). Twin model
fitting and (genetic) association analyses were performed.
Results: Intra-pair correlations of FEV1 and FVC did not differ significantly between MZ mono-
chorionic and MZ dichorionic pairs. Heritability estimates of FEV1 and FVC were 69% and 63%,
respectively. The A allele of the LEP 19G>A SNP was significantly associated with a lower FEV1
(pAdditiveZ 0.01) and FVC (pDominantZ 0.047), while the LEPR K109R and Q223R SNPs showed no
associations. Accounting for body mass index, serum leptin was negatively associated with FVC3881327.
ichtuniversity.nl (B. van den Borst).
to this manuscript.
1 Elsevier Ltd. All rights reserved.
236 B. van den Borst et al.(p Z 0.02) in men, but not in women.
Conclusions: More than 60% of variation in maximally attained FEV1 and FVC is explained by
genetic factors. Moreover, these results suggest that leptin may be important in the determi-
nation of maximally attainable lung function.
ª 2011 Elsevier Ltd. All rights reserved.Introduction
A lower maximally attained lung function is considered
a risk factor for the development of Chronic Obstructive
Pulmonary Disease (COPD).1,2 The level of maximally
attained lung function is determined by both environ-
mental and genetic factors and to get a better under-
standing of the pathogenesis of COPD, much research is
currently focused on the genetic component.3e5 To unravel
the genetics of lung function, it is of great interest to
assess the size of the genetic component contributing to
lung function parameters. Heritability is a commonly used
measure to quantify to what extent genetic factors explain
the total variance of a trait.6 Heritabilities can in principle
be estimated from all kinds of related individuals, but twin
studies allow the variation to be split into genetic, shared
environmental and unique environmental components,
thus offering one of the most valid estimations.7 Twin
studies reporting the genetic influences on lung function
are mainly performed in adult populations
(age > 40 y).8e13 Considering the physiological course of
lung function during life, which is characterized by a peak
around the age of twenty-five,14 it is of interest to perform
such studies in young adults.
Leptin exerts its biological function by binding to the
leptin receptor which is present in many tissues, including
lung epithelium.15 Leptin is primarily produced by adipo-
cytes, but is also expressed in alveolar macrophages and
pulmonary epithelium.15,16 Whereas leptin was initially
identified as a satiety signal regulating food intake and
energy expenditure, it is now regarded as a pluripotent
protein that is implicated in a wide range of body func-
tions, including the inflammatory response and angiogen-
esis.17,18 For example, leptin has been shown to induce
cytokine production of monocytes/macrophages, aid in
the activation and chemotaxis of neutrophils and increases
the cytotoxicity of natural killer cells.18 In addition to
these actions of leptin, evidence from animal studies
suggests that leptin is also involved in the regulation of
embryonic lung growth and maturation.19,20 Leptin and its
receptor are expressed in fetal type 2 pneumocytes and
stimulation of these cells with leptin results in an
increased surfactant-related protein production.20,21 In
mice, antenatal administration of leptin results in
increased pulmonary cellularity of the newborn, indicative
of improved lung development.20 Leptin-deficient mice
are characterized by impaired alveolar formation and
lower lung volumes at birth. Notably, postnatal leptin
replacement in these mice increased the alveolar count
and lung volumes.19 These experimental data congruently
suggest that proper functioning of both leptin and its
receptor is necessary for normal lung growth and
maturation.In COPD, leptin has attracted growing interest with
respect to its potential role in the pulmonary and systemic
inflammatory response.22 Upon an acute exacerbation
serum leptin levels have been reported to be increased
which is in analogy to pro-inflammatory cytokines.23 Bron-
chial expression of leptin was found to be increased in
COPD and lung epithelium contains an active leptin
receptor.16 Recently, single nucleotide polymorphisms
(SNPs) in the leptin receptor (LEPR) gene were associated
with a decline in forced expiratory volume in 1 s (FEV1) in
COPD patients, indicating that LEPR polymorphisms might
be related to pulmonary disease risk.24
In the present study, we investigated to what extent
genetic factors explain the variation in maximally attained
lung function parameters determined in young adulthood
(18e34 years), by estimating the heritabilities of maximally
attained FEV1 and forced vital capacity (FVC) in young adult
twins. Subsequently, we analysed whether common SNPs in
the LEP (19G>A) gene and its receptor (K109R and Q223R)
explain some of the genetic variation observed for the lung
function measures. In addition, we examined whether
serum leptin levels are associated with measures of lung
function.
Methods
Participants and phenotypic measurements
Twins were recruited from the population-based East
Flanders Prospective Twin Survey (EFPTS), which started in
1964 and has been recording all multiple births in the
Belgian Province of East Flanders until the present.25
Between February 1997 and April 2000, 424 twins visited
the research center in Leuven (Belgium), which started in
the morning after an overnight fast. Participants were
measured barefoot and lightly clothed. Standing height
(cm) was measured to the nearest 0.1 cm with a Harpenden
fixed stadiometer (Holtain, Crosswell, UK). Body mass (kg)
was measured on a balance scale (SECA, Hamburg,
Germany) to the nearest 0.1 kg. Body mass index (BMI) was
calculated as body mass divided by the square of height
(kg/m2). Fat-free mass was measured using a bioelectrical
impedance analyser (BIA310; Biodynamics, Seattle, WA,
USA). Fat mass (kg) was calculated by subtracting the value
for fat-free mass from the total body mass. From the body
fat measurements, fat mass index and fat-free mass index
were calculated as fat (or fat-free) mass divided by the
square of height (kg/m2). Plasma leptin concentrations
were measured using an immunoradiometric assay in
a coated tube (Diagnostic Systems Laboratories, Webster,
TX, USA). Lung function was measured with Spirobank
(Medical International Research, Waukesha, WI, USA)
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reproducible tests had to be obtained, and measured
volumes had to be within a 5% range. The highest obtained
values were used. After excluding those participants whose
lung function test did not meet the criteria for accep-
tance,26 578 individuals were included in the present study,
including 165 monozygotic (MZ) and 73 dizygotic (DZ)
complete twin pairs and 102 single twins (47 MZ, 55 DZ).
Birth weights were obtained from obstetric records, and
gestational age reported by the obstetrician was calculated
as the number of completed weeks of pregnancy based on
the last menstrual period. Zygosity was determined using
sequential analysis based on sex, fetal membranes, umbil-
ical cord blood groups, placental alkaline phosphatase and
DNA marker analysis. The Ethics Committee of the Faculty
of Medicine of the Katholieke Universiteit Leuven approved
the project and all participants gave informed consent.
DNA isolation and genotyping
As previously described,27 genomic DNA was initially
extracted from available placental tissue collected at birth
and/or twins were contacted and whole blood or mouth
swabs were taken for DNA extraction. The DNA mini kit
(Qiagen, Venlo, the Netherlands) was used for placental
and mouth swab DNA extraction, the Wizard kit (Promega,
Leiden, the Netherlands) was used for blood DNA extrac-
tion, both according to manufacturer’s instructions.
Only putative functional polymorphisms were analysed
(functionality has not been proven yet), including the LEPR
K109R SNP (rs1137100) in exon 4, the LEPR Q223R SNP
(rs1137101) in exon 6 and the LEP 19G>A SNP (rs2167270)
located in the untranslated exon 1 (in LEP no common
nonsynonymous SNPs have been identified). The SNPs were
genotyped using pyrosequencing technology (Pyrose-
quencing AB, Uppsala, Sweden) in the Genome Center
Maastricht of Maastricht University Medical Center. PCR
conditions and primer sequences have been previously
described in detail.27 Pyrosequencing was performed for
sequence determination and allele designation in a Biot-
age PSQ HS 96A System according to the manufacturer’s
instructions. Prior to genotyping, 20 samples (including all
3 possible genotypes) were sequenced directly to validate
the assays. No discrepancies were observed. The geno-
typing success rate for LEP 19G>A, LEPR K109R SNP and
LEPR Q223R SNP was 95%, 98% and 96%, respectively. A c2-
test (1 df ) was used to check for Hardy-Weinberg
proportions among genotype frequencies of the SNPs,
using only one randomly selected twin per pair (see Souren
et al.27 for genotype/allele frequencies). All genotype
frequencies were in accordance with Hardy-Weinberg
equilibrium (p > 0.20). Since not all participants of whom
data on long function parameters were available were
willing to provide DNA, genotypes were available of
maximal 440 individuals.
General statistical analysis
Differences in means between men and women and MZ and
DZ twins were calculated using the PROC MIXED method
implemented in the SAS package (version 9.2, SAS Institute).A random intercept model was used, where the intercept of
each twin pair was modelled as a function of the population
intercept plus a unique contribution of the pair. Further-
more, the variance-covariance structure of the random
intercept was allowed to differ between MZ and DZ pairs.
Variables with a skewed distribution were transformed to
a natural logarithmic scalewhen performing statistical tests.
For the lung function parameters, the effect of the potential
covariates sex, age, height, birth weight and smoking status
(current, former and never smokers) were checked using the
PROC MIXED method. A covariate was considered significant
if p < 0.10 (see Table 2). Intra-pair correlation coefficients
were calculated according to chorionicity and zygosity
status, after adjustment for significant covariates. To
examine whether chorion-type of MZ twins biases the heri-
tability estimates, linear regression analysis was carried out
to test whether twin correlations differed between MZ
monochorionic (MC) and MZ dichorionic (DC) twins.Heritability analysis
Twin methodology makes use of the fact that MZ twins are
genetically identical, whereas DZ twins share on average 50%
of their segregating genes. Assuming that MZ and DZ twins
share their common environment to the same extent,
a higher within-pair concordance rate in MZ twins than in DZ
twins reflects genetic influences. To estimate the genetic
and environmental components of variance of the traits,
twin model fitting of raw data was implemented using the
statistical package Mx.28 Scripts were downloaded from the
GenomEUtwin Mx-script library (http://www.psy.vu.nl/
mxbib/). Univariate twin analyses were performed, where
the phenotypic variance can be decomposed into additive
genetic (A, additive effects of genes on multiple loci), non-
additive genetic (D, interactions between alleles at the
same locus (dominance) or on different loci (epistasis)),
common environmental (C, environmental effects shared by
twins reared in the same family) and unique environmental
effects (E, non-shared environmental effects unique to the
individual). MZ twins are assumed to share the same A and D
genetic variance; DZ pairs are assumed to share half of the A
variance and a quarter of the D variance. The C variance is
assumed to be the same for both MZ and DZ twin pairs. The
broad-sense heritability (H2), which estimates the extent to
which variation of a trait in a population can be explained by
genetic variation, is defined as the proportion of genetic
variance to total phenotypic variance. As non-additive
genetic (D) and shared environmental effects (C) cannot be
identified simultaneously in data from twins reared together,
ACE and ADE models were fitted separately. The significance
of variance components A, C or D in the model was tested by
dropping these parameters and comparing the fit of the
models.
To test whether genetic and environmental factors
influence a trait to the same degree in men and women, we
compared a quantitative heterogeneity model (variance
components free to differ across sexes) with a homogeneity
model (variance components constrained to be equal for
both sexes). In addition, we verified whether the distribu-
tion of a trait differed among men and women by testing
a scalar model, which assumes that the female variance
Table 1 Phenotypic characteristics of the twin sample according to sex and zygosity status.
Trait Sex p Zygosity p
Men Women MZ DZ
n 272 306 377 201
Gestational age (wks) 37.0  2.3 37.1  2.5 0.59a 36.9  2.4 37.4  2.5 0.009a
Birth weight (g) 2581  467 2490  491 0.02 2492  485 2610  467 0.02
Age (yrs)a 24.8  4.4 25.1  4.7 0.50a 24.6  4.4 25.7  4.7 0.007a
Height (cm) 178.6  6.2 165.5  6.1 <0.0001 171.3  9.1 172.4  8.7 0.31
Weight (kg) 70.1  9.3 60.5  9.8 <0.0001 64.5  10.7 66.0  10.6 0.18
BMI (kg/m2)b 21.7  1.1 21.9  1.2 0.90 21.7  1.1 21.9  1.1 0.46
Fat mass indexb 3.6  1.5 6.1  1.3 <0.0001 4.7  1.6 4.8  1.5 0.65
Fat-free mass index 18.1  1.6 15.7  1.7 <0.0001 16.7  1.9 16.9  2.1 0.34
FEV1 (L) 4.6  0.7 3.3  0.5 <0.0001 3.9  0.9 4.0  0.9 0.30
FVC (L) 5.6  0.8 3.9  0.6 <0.0001 4.6  1.1 4.7  1.0 0.52
Leptin (ng/ml)b 1.5  2.9 11.7  2.1 <0.0001 4.4  3.9 4.3  3.9 0.93
BMI Z body mass index, FEV1 Z forced expiratory volume in the first second, FVC Z forced vital capacity. Data are expressed as
mean  SD unless stated otherwise.
a p-value calculated using standard linear regression, because convergence criteria could not be met using a random intercept model.
b Transformed to natural logarithmic scale and for these variables the geometric mean  SD is presented.
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components. In this model the variance components were
constrained to be equal for both sexes, but total variances
were allowed to differ between men and women.29
Variance components were estimated adjusted for signif-
icant covariates by modelling the covariates as definition
variables in the means model. The difference in fit between
the nestedmodels was evaluated with the likelihood ratio c2-
test, which uses the difference between the e2log likelihood
of the full and the restricted model. This difference is
distributed as c2. The df of the test were calculated as the
difference in df between the models. When the c2 was not
statistically significant (p < 0.05), the most parsimonious
model was selected, i.e. themodel with the best fit given the
number of df. When comparing the fit of non-nested models
(e.g. ACE with ADE), the model with the lowest Akaike’s
information criterion (AIC) was preferred.(Genetic) association analyses
The relation between maximally attained lung function and
serum leptin levels was analysed, unadjusted and adjustedTable 2 Intra-pair correlations of maximally attained lung fu
confidence interval) of the best fitting models expressed in perce
Trait MZ DZ Model a2 (H2)
All MC DC All
n 165 93 72 73
FEV1 0.74 0.73 0.75 0.18 DE
FVC 0.68 0.65 0.71 0.38 AE 63 (54e70)
a2 Z additive genetic variance, c2 Z common environmental var
e2 Z unique environmental variance, FEV1 Z forced expiratory volum
sense heritability, M Z men, MC Z monochorionic, n Z number of p
a Smoking status not significant.for body composition in men and women separately, using
the PROC MIXED method as described above. Associations
between the LEP and LEPR SNPs and the lung function
parameters were also analysed using the PROC MIXED
method, adjusted for significant covariates. Models
assuming an additive, dominant and recessive mode of
inheritance were tested and an association was considered
significant if the p-value <0.05. The genetic association
study has 80% power to detect a difference between two
means with an effect size (Cohen’s d) of approximately
0.28, assuming a significance threshold of 0.05 and
a group-size ratio (e.g. nKK:nxR) of 1:2. Effect sizes of 0.20,
0.50 and 0.80 are defined as small, medium and large,
respectively.30
Results
General statistical analysis
Compared to women, men were taller and heavier, had
a higher birth weight, fat-free mass index, higher FEV1 and
FVC, but lower fat mass index and leptin levels (p < 0.05)nction parameters and variance components estimates (95%
ntages; adjusted for significant covariates.
c2 d2 (H2) e2 S Significant
covariatesa
69 (61e75) 31 (25e39) M > W Sex, height and
birth weight
37 (30e46) M > W Sex, height,
age and
birth weight
iance, d2 Z non-additive genetic variance, DC Z dichorionic,
e in the first second, FVC Z forced vital capacity, H2 Z broad-
airs, S Z scalar effect, W Z women.
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gestational age and were younger than DZ twins (p < 0.05).
In addition, FEV1 and FVC did not differ between current
(n Z 172), former (n Z 39) and never (n Z 366) smokers
(FEV1 current, former and never smokers (mean  SD):
3.9  0.9, 3.8  0.8 and 3.9  0.9 L, respectively, pZ 0.56;
FVC current, former and never smokers: 4.7  1.1,
4.6  1.2 and 4.6  1.1 L, respectively, p Z 0.64).
Intra-pair correlations of FEV1 and FVC were higher in
MZ-DC compared to MZ-MC twins, but did not differ signif-
icantly (p > 0.05) (Table 2). For FEV1, the DZ correlations
were less than half of the MZ correlations, suggesting that
non-additive genetic effects might be important. The intra-
pair correlations for the FVC were in agreement with
a model containing additive genetic and unique environ-
mental influences (Table 2).
Heritability analysis
For FEV1, the best fitting model was a DE model containing
a non-additive genetic and unique environmental compo-
nent (Table 2). For FVC, the variation was best explained by
an AE model containing an additive genetic and unique
environmental component (Table 2). The broad-sense
heritability estimates (encompassing both additive and
non-additive genetic effects) of FEV1 and FVC were 69 and
63%, respectively (Table 2).
For both FEV1 and FVC, scalar sex differences were
observed, indicating that although variance components
are equal across sexes, the total variances differ. Total
variances of FEV1 and FVC were larger in men compared to
women.
(Genetic) association analysis
The A allele of the LEP 19G>A SNP was associated with
a lower FEV1 and a lower FVC (p < 0.05). For FEV1 the
model assuming an additive mode of inheritance was mostTable 3 Associations between SNPs in the LEP and LEPR gene a
covariates.
Gene (SNP) Trait Genotype
LEP 19G>A GG GA
(rs2167270) n 161 206
FEV1 (L) 3.95 (3.86e4.03) 3.86 (3.79e3.94)
FVC (L) 4.75 (4.64e4.86) 4.62 (4.52e4.72)
LEPR K109R KK KR
(rs1137100) n 267 137
FEV1 (L) 3.86 (3.79e3.92) 3.89 (3.80e3.98)
FVC (L) 4.65 (4.57e4.73) 4.67 (4.55e4.78)
LEPR Q223R QQ QR
(rs1137101) n 137 223
FEV1 (L) 3.86 (3.77e3.96) 3.91 (3.84e3.99)
FVC (L) 4.71 (4.59e4.82) 4.67 (4.58e4.77)
FEV1 Z forced expiratory volume in the first second, FVC Z forced
confidence interval (CI)), calculated using a 2 df F-test and adjusting f
value additive model, pD Z p-value dominant model, pR Z p-value r
birth weight. FVC analyses were adjusted for sex, age, height and bisignificant (p Z 0.01), while for FVC the dominant model
had the lowest p-value (p Z 0.047). The LEPR K109R and
Q223R SNPs showed no association (p > 0.25) with the lung
function parameters (Table 3). As reported previously in
this cohort, the LEP and LEPR SNPs showed no association
with serum leptin levels.27
In men, serum leptin levels were negatively associated
with FVC (pZ 0.02), but only after adjusting for BMI (Table
S1). No significant associations between lung function
parameters and serum leptin levels were observed in
women (Table S1).Discussion
In this study, we assessed the size of the genetic component
contributing to maximally attained lung function by esti-
mating the heritabilities of FEV1 and FVC in young adult
twins recruited from the EFPTS. In our sample, 69% and 63%
of the total variation in maximally attained FEV1 and FVC
was explained by genetic factors, respectively. One study in
a younger twin sample (mean age 19 years) failed to iden-
tify significant heritabilities for FEV1 and FVC,
31 which
might be due to their relatively small sample size (74 twin
pairs). Conversely, twin studies in older samples revealed
heritability estimates for FEV1 and FVC between 32 and
91%.8e13 While it has been shown that the genetic influence
on lung function is modified by smoking status,11,12 we did
not observe a significant effect of cigarette exposure. This
is probably the result of the relatively low pack years
exposure in our young sample.
Low birth weight, a proxy for a poor prenatal environ-
ment, has been associated with reduced lung function in
adulthood.32,33 Compared to MZ-DC and DZ twins, MZ-MC
twins experience a more adverse prenatal environment,
which is translated in a lower birth weight and higher
perinatal mortality and morbidity.25 Since the classical twin
design assumes equal prenatal environment for MZ-MC, MZ-
DC and DZ twins, this design might be an unreliable methodnd maximally attained lung function; adjusted for significant
b (SE) pA pD pR
AA
58
3.74 (3.60e3.88) 0.10(0.04) 0.011 0.039 0.033
4.60 (4.43e4.76) 0.09(0.05) 0.064 0.047 0.392
RR
36
3.97 (3.79e4.15) 0.05 (0.04) 0.255 0.359 0.310
4.72 (4.50e4.94) 0.03 (0.05) 0.584 0.697 0.572
RR
69
3.90 (3.76e4.04) 0.03 (0.04) 0.534 0.407 0.946
4.65 (4.48e4.82) 0.03(0.05) 0.548 0.577 0.710
vital capacity. Data are expressed as least squares mean (95%
or significant covariates. nZ total number of individuals. pAZ p-
ecessive model. FEV1 analyses were adjusted for sex, height and
rth weight. Smoking status was no significant covariate.
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However, in contrast to previous twin studies that exam-
ined the heritability of lung function, we were able to
control for birth weight and chorion-type in our analyses.
Although the intra-pair correlations for FEV1 and FVC
(controlled for birth weight) were slightly higher in MZ-DC
compared to MZ-MC twins, they did not differ signifi-
cantly. This suggests that the heritability estimates pre-
sented here are not biased by chorion-type. Nevertheless,
failure to detect a significant difference due to low power
cannot be excluded.
We are the first to report a model containing non-
additive genetic factors as the best fitting model for
FEV1. However, Redline et al.
13 reported for FEV1 a DZ
correlation of less than one-half of the MZ correlation,
which also indicates that non-additive genetic factors play
a role. The presence of non-additive genetic effects implies
that part of the variation is explained by within-locus
interactions (dominance) and/or between-locus interac-
tions (epistasis). In addition to the non-additive genetic
component, one would expect that additive genetic factors
also explain part of the total variation in FEV1. However,
the identification of a model containing both an additive
genetic and a non-additive genetic component (ADE model)
requires greater statistical power, which is a limitation of
this heritability analysis. In addition, one should keep in
mind that heritabilities are specific for a particular pop-
ulation at a particular moment in time and cannot be
generalized to other populations.34 This means for instance
that if the environment becomes more heterogeneous, the
environmental variance will increase and the heritability
will reduce and vice versa.
Knowledge on which genetic variants contribute to the
genetic components underlying FEV1 and FVC may eventu-
ally aid in the development of more personalized diagnos-
tics, treatment and prevention strategies. These genetic
variants may either alone (e.g. a1-antitrypsin variant) or in
combination with others a (e.g. a-nicotinic acetylcholine
receptor 3/5 and hedgehog interacting protein poly-
morphisms) predict lung disease.35,36 In this study, we
examined whether common SNPs in the LEP (19G>A) gene
and its receptor (K109R and Q223R) account for some of the
genetic variation observed for the lung function measures.
Recently, Hansel et al.24 reported that the R allele of the
LEPR K109R SNP was associated with an attenuation in
annual FEV1 decline in COPD patients. We did not observe
a significant association between the lung function
measures and the LEPR K109R and/or Q223R SNP. However,
in our sample R allele carriers of the LEPR K109R SNP had
a slightly higher lung function compared to the K allele
carriers, which is in agreement with the protective effect
of the R allele reported by Hansel et al.24 Since our sample
size is similar to the sample size of Hansel et al.,24 the
absence of a significant association cannot be attributed to
lower statistical power. Nevertheless, Hansel et al.24
studied middle-aged smoking COPD patients and therefore
our insignificant results might also indicate that the effect
of the LEPR SNP is modified by smoking and/or disease
status.
Although the LEPR SNPs were not significantly associated
with the lung function measures, the A allele of the LEP
19G>A SNP showed a significant association with a lowerFEV1 and a lower FVC. To our knowledge, we are the first
examining the relation between a SNP in the LEP gene and
lung function measures, thus additional studies in other
populations are required to confirm this association. Since
this SNP is located in the 50 untranslated region, it might
alter expression levels of LEP. Hager et al.37 reported that
the A allele of the LEP 19G>A SNP was associated with
increased serum leptin levels, but other studies failed to
replicate this association.38,39 Also in our twin sample, the
LEP 19G>A SNP was not associated with serum leptin
levels.27 Since adipose tissue is the main source of circu-
lating leptin, lack of association with serum leptin levels
indicates that the LEP 19G>A SNP has probably no func-
tional consequences in adipocytes, which does not rule out
functional relevance in other cells such as alveolar cells. To
underline a differential pattern of systemic versus local
leptin action, we recently showed an inverse association
between serum leptin and sputum leptin in COPD.40 If the
LEP 19G>A SNP, or a SNP in linkage disequilibrium with the
LEP 19G>A SNP, affects LEP expression locally in the
developing lung, it may interfere with the regulation of
normal lung growth. A feasible next approach to get more
insight into a potential local effect of LEP SNPs could be to
examine their relation with leptin expression in lung
biopsies.
Eventually, we examined whether serum leptin levels
were associated with measures of lung function. While in
a large middle-aged US sample an independent relation
between impaired FEV1 and increased serum leptin levels
has been reported,41 in our sample serum leptin levels
were not associated with FEV1. This might be due to the
small range of FEV1 in our study as in the US study data
from 2808 individuals were analysed, providing adequate
statistical power for the identification of small effects.
Nevertheless, in men, serum leptin levels were negatively
associated with FVC, but only after adjusting for BMI.
Because of the large number of tests performed, we want
to emphasize that this association should be interpreted
cautiously, because this might reflect a random association
by chance. However, our results are supported by
a recently published study of Hickson et al. (including 4679
AfricaneAmerican men and women), who observed an
inverse association between serum leptin and FEV1 and FVC
% predicted, independent of adiposity, which was more
pronounced in men and absent in women with a normal
body weight.42 Finally, childhood lung infection and asthma
were previously related to increased plasma leptin levels,43
and may be related to maximally attained lung function.2
However, because we did not observe a clear relation
between plasma leptin and lung function, this was unlikely
to confound our results.
In conclusion, this classical twin study reveals that in
this young adult twin sample the total variation in maxi-
mally attained FEV1 and FVC is to a large extent explained
by genetic factors. Genetic association analyses with SNPs
in the LEP and LEPR genes, revealed that the LEP 19G>A
SNP was associated with a lower FEV1 and a lower FVC. This
association needs to be confirmed in other populations and
future studies should address whether the LEP 19G>A SNP
has functional consequences and underlies a local patho-
physiological mechanism related to impaired lung
development.
Genetics of maximally attained lung function: A role for leptin? 241Conflict of interest
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